NASDAQ · GLUE

Monte Rosa Therapeutics, Inc.

Healthcare · Biotechnology

$12.65

Down-$0.05 (-0.40%)

Updated Sep 18, 2026, 1:57 AM

SID Score

3.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 1.08B
P/E ratio: 56.25
Dividend yield: 0.00%
52-week range: $6.25 – $25.77
Volume: 1.5M
Avg. volume: 1.57M

Price performance

GLUE price history

1M range · 19 trading sessions · Daily adjusted prices

Last close: $12.65
Period change: -14.41%
Period low: $12.65
Period high: $14.78

Daily close

View OHLC price history

GLUE OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Sep 16, 2026	$12.94	$13.01	$12.59	$12.65	1.5M
Sep 15, 2026	$13.84	$13.88	$12.87	$12.99	1.27M
Sep 14, 2026	$14.35	$14.38	$13.38	$13.90	1.79M
Sep 11, 2026	$14.235	$14.74	$13.88	$14.07	1.17M
Sep 10, 2026	$14.21	$14.34	$13.83	$14.32	1.06M
Sep 9, 2026	$14.28	$14.87	$14.13	$14.26	1.15M
Sep 8, 2026	$13.55	$14.29	$13.44	$14.27	1.2M
Sep 4, 2026	$14.12	$14.31	$13.79	$13.84	804.59K
Sep 3, 2026	$14.50	$14.59	$14.06	$14.38	672.73K
Sep 2, 2026	$14.38	$15.00	$13.81	$14.22	1.53M
Sep 1, 2026	$13.81	$14.32	$13.71	$14.31	796.29K
Aug 31, 2026	$13.39	$14.11	$13.12	$13.94	1.11M
Aug 28, 2026	$14.29	$14.30	$13.37	$13.38	884.65K
Aug 27, 2026	$14.28	$14.57	$14.19	$14.32	1.08M
Aug 26, 2026	$14.44	$14.6248	$14.10	$14.38	997.72K
Aug 25, 2026	$14.06	$14.8399	$14.00	$14.56	1.1M
Aug 24, 2026	$14.03	$14.29	$13.29	$13.775	2M
Aug 21, 2026	$14.80	$15.00	$14.17	$14.30	969.16K
Aug 20, 2026	$15.62	$15.90	$14.715	$14.78	1.02M

Latest GLUE news

The latest Smart Investors Daily articles mentioning GLUE.

priceAug 19, 2026

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.1% on Heavy Volume

priceJul 7, 2026

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.5% on Heavy Volume

analystJul 1, 2026

Guggenheim Reiterates Buy Rating on Monte Rosa Therapeutics, Inc. (GLUE)

Latest GLUE news

The latest Smart Investors Daily articles mentioning GLUE.

Stock researchResearch & News · SEC Filings

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

GLUE research

SEC Filings

Recent regulatory filings and source documents.

SEC filing history

Open a filing to view the original source document.

GLUE SEC filings
Filed	Form	Description	Accepted	Document
Sep 8, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Aug 6, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 6, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Jul 17, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 16, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 6, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 30, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 30, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 25, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 25, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 25, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 18, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 18, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 7, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 7, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Apr 29, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Mar 17, 2026	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Mar 17, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Feb 10, 2026	8-K	Form 8-K - Current report - Item 5.02	—	Open source
Jan 9, 2026	8-K	Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01	—	Open source
Jan 7, 2026	8-K	Form 8-K - Current report - Item 8.01 Item 9.01	—	Open source
Nov 6, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 6, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Sep 15, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 7.01 Item 9.01	—	Open source
Aug 7, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 7, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 16, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 13, 2025	8-K	Form 8-K - Current report - Item 5.07	—	Open source
Jun 4, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 8, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 8, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Apr 25, 2025	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Mar 25, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Mar 20, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Mar 20, 2025	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans	—	Open source
Mar 20, 2025	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Mar 20, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Jan 10, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Jan 6, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jan 6, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jan 6, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jan 6, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source

Filed

Form

Description

Accepted

Document

Sep 8, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 6, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Jul 17, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 16, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 6, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 30, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 30, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 25, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 25, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 25, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 18, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 18, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 7, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Apr 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Mar 17, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Mar 17, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Feb 10, 2026

8-K

Form 8-K - Current report - Item 5.02

—

Open source

Jan 9, 2026

8-K

Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01

—

Open source

Jan 7, 2026

8-K

Form 8-K - Current report - Item 8.01 Item 9.01

—

Open source

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 6, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Sep 15, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 7.01 Item 9.01

—

Open source

Aug 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 7, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 16, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 13, 2025

8-K

Form 8-K - Current report - Item 5.07

—

Open source

Jun 4, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 8, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 8, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Apr 25, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Mar 25, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Mar 20, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Mar 20, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

—

Open source

Mar 20, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Mar 20, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Jan 10, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Jan 6, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jan 6, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jan 6, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jan 6, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.1% on Heavy Volume

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.5% on Heavy Volume

Guggenheim Reiterates Buy Rating on Monte Rosa Therapeutics, Inc. (GLUE)

Featured By

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.1% on Heavy Volume

Monte Rosa Therapeutics, Inc. (GLUE) Surges 5.5% on Heavy Volume

Guggenheim Reiterates Buy Rating on Monte Rosa Therapeutics, Inc. (GLUE)